Khuskia oryzae

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT

Full Drug Profiles

Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.

SUBSCRIBERECOMMENDED FOR PHARMA

Data Packages

Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Summary

Khuskia oryzae is an extract from Khuskia oryzae used in allergy testing.

Generic Name

Khuskia oryzae

DrugBank Accession Number

DB10581

Background

Khuskia oryzae is a fungus which can provoke allergic reactions. Khuskia oryzae extract is used in allergenic testing.

Type

Biotech

Groups

Approved

Biologic Classification

Allergenics
Allergen Extract

Synonyms

Not Available

Get Early Access To DrugBank+

Be among the first to try our new AI-powered, game-changing platform. DrugBank+ is here to streamline your pharmaceutical research and deliver faster insights and smarter decisions.

Join the Waitlist

Get Early Access To DrugBank+

Join the Waitlist

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Unlock the secrets to drugging the undruggable

Discover how groundbreaking research is turning "undruggable" targets into therapeutic opportunities.

Download eBook

Unlock the secrets to drugging the undruggable

Download eBook

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	Region	Image
Khuskia Oryzae	Injection, solution	0.10 g/1mL	Percutaneous	ALK-Abello, Inc.	1965-01-01	2021-11-30
Nigrospora	Injection, solution	0.05 g/1mL	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1974-03-23	Not applicable
Nigrospora	Injection, solution	0.1 g/1mL	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1992-04-13	Not applicable
Nigrospora sphaerica	Injection, solution	10000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Nigrospora sphaerica	Injection, solution	0.05 g/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
B Mold Mixture	Khuskia oryzae (0.0071 g/1mL) + Cochliobolus spicifer (0.0071 g/1mL) + Colletotrichum coccodes (0.0071 g/1mL) + Hypomyces perniciosus (0.0071 g/1mL) + Microascus brevicaulis (0.0071 g/1mL) + Myrothecium verrucaria (0.0071 g/1mL) + Neurospora crassa (0.0071 g/1mL) + Paecilomyces variotii (0.0071 g/1mL) + Passalora fulva (0.0071 g/1mL) + Pleospora herbarum (0.0071 g/1mL) + Streptomyces griseus (0.0071 g/1mL) + Trichoderma viride (0.0071 g/1mL) + Trichophyton schoenleinii (0.0071 g/1mL) + Trichothecium roseum (0.0071 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1992-04-13	Not applicable
B Mold Mixture	Khuskia oryzae (0.0036 g/1mL) + Cochliobolus spicifer (0.0036 g/1mL) + Colletotrichum coccodes (0.0036 g/1mL) + Hypomyces perniciosus (0.0036 g/1mL) + Microascus brevicaulis (0.0036 g/1mL) + Myrothecium verrucaria (0.0036 g/1mL) + Neurospora crassa (0.0036 g/1mL) + Paecilomyces variotii (0.0036 g/1mL) + Passalora fulva (0.0036 g/1mL) + Pleospora herbarum (0.0036 g/1mL) + Streptomyces griseus (0.0036 g/1mL) + Trichoderma viride (0.0036 g/1mL) + Trichophyton schoenleinii (0.0036 g/1mL) + Trichothecium roseum (0.0036 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1974-03-23	Not applicable
B Mold Mixture	Khuskia oryzae (0.0018 g/1mL) + Cochliobolus spicifer (0.0018 g/1mL) + Colletotrichum coccodes (0.0018 g/1mL) + Hypomyces perniciosus (0.0018 g/1mL) + Microascus brevicaulis (0.0018 g/1mL) + Myrothecium verrucaria (0.0018 g/1mL) + Neurospora crassa (0.0018 g/1mL) + Paecilomyces variotii (0.0036 g/1mL) + Passalora fulva (0.0018 g/1mL) + Pleospora herbarum (0.0018 g/1mL) + Streptomyces griseus (0.0018 g/1mL) + Trichoderma viride (0.0018 g/1mL) + Trichophyton schoenleinii (0.0018 g/1mL) + Trichothecium roseum (0.0018 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1974-03-23	Not applicable
Rinkel Mold Mix B	Khuskia oryzae (0.071 g/20mL) + Cochliobolus spicifer (0.071 g/20mL) + Helminthosporium solani (0.072 g/20mL) + Microascus brevicaulis (0.072 g/20mL) + Mycogone nigra (0.071 g/20mL) + Myrothecium verrucaria (0.071 g/20mL) + Neurospora crassa (0.071 g/20mL) + Paecilomyces variotii (0.072 g/20mL) + Passalora fulva (0.071 g/20mL) + Pleospora tarda (0.072 g/20mL) + Streptomyces griseus (0.072 g/20mL) + Trichoderma viride (0.072 g/20mL) + Trichophyton schoenleinii (0.071 g/20mL) + Trichothecium roseum (0.071 g/20mL)	Injection, solution	Percutaneous; Subcutaneous	Allergy Laboratories, Inc.	1967-12-07	Not applicable
Treatment Set TS128871	Khuskia oryzae (0.00036 g/1mL) + Acrothecium robustum (0.00042 g/1mL) + Apiospora montagnei (0.00042 g/1mL) + Canis lupus familiaris hair (0.005 g/1mL) + Cladosporium cladosporioides (0.005 g/1mL) + Cochliobolus spicifer (0.00036 g/1mL) + Colletotrichum coccodes (0.00036 g/1mL) + Felis catus hair (500 [BAU]/1mL) + Humicola grisea (0.00042 g/1mL) + Hypomyces perniciosus (0.00036 g/1mL) + Microascus brevicaulis (0.00036 g/1mL) + Microsporum audouinii (0.00042 g/1mL) + Microsporum canis (0.00042 g/1mL) + Mycocladus corymbiferus (0.00042 g/1mL) + Myrothecium verrucaria (0.00036 g/1mL) + Neurospora crassa (0.00036 g/1mL) + Paecilomyces variotii (0.00036 g/1mL) + Passalora fulva (0.00036 g/1mL) + Phycomyces blakesleeanus (0.00042 g/1mL) + Pleospora herbarum (0.00036 g/1mL) + Sarocladium strictum (0.005 g/1mL) + Sporisorium cruentum (0.0025 g/1mL) + Sporotrichum pruinosum (0.00042 g/1mL) + Stachybotrys chartarum (0.00042 g/1mL) + Streptomyces griseus (0.00036 g/1mL) + Syncephalastrum racemosum (0.00042 g/1mL) + Tetracoccosporium paxianum (0.00042 g/1mL) + Trichoderma viride (0.00036 g/1mL) + Trichophyton schoenleinii (0.00036 g/1mL) + Trichothecium roseum (0.00036 g/1mL) + Ustilago cynodontis (0.0025 g/1mL) + Verticillium albo-atrum (0.00042 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1986-10-31	Not applicable

Categories

Drug Categories

• Cell-mediated Immunity
• Increased Histamine Release
• Increased IgG Production
• Non-Standardized Fungal Allergenic Extract

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

VK8C112WTS

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347910740

RxNav

892338

Wikipedia

Khuskia_oryzae

Clinical Trials

Clinical Trials

Clinical Trial & Rare Diseases Add-on Data Package

Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package

Phase	Status	Purpose	Conditions	Count	Start Date	Why Stopped	100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data

Unlock 75,000+ rows when you subscribe

Explore data packages curated & structured to speed up your pharmaceutical research

View Sample Data

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Injection, solution	Intradermal; Subcutaneous
Injection, solution	Percutaneous	0.10 g/1mL
Injection, solution	Intradermal; Subcutaneous	0.05 g/1mL
Injection, solution	Intradermal; Subcutaneous	0.1 g/1mL
Injection, solution	Intradermal; Subcutaneous	10000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	20000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	40000 [PNU]/1mL
Injection, solution	Percutaneous; Subcutaneous	1 g/20mL
Injection, solution	Percutaneous; Subcutaneous

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53